Crossmark

Pharmacovigilance study and development of a clinical decision flowchart for personalized selection of trastuzumab, T-DXd, and T-DM1 in breast cancer patients

Crossref DOI link: https://doi.org/10.1007/s12094-025-04190-8

Published Online: 2026-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Xiaohu

Pei, Xiaomei

Song, Chunli

Kong, Lingti https://orcid.org/0000-0003-0769-9363
Funding

Funding for this research was provided by:

Natural Science Foundation of Bengbu Medical University (2023byzd060)
License Information

Text and Data Mining valid from 2026-01-10

Version of Record valid from 2026-01-10
More Information

Article History

Received: 21 October 2025

Accepted: 13 December 2025

First Online: 10 January 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below